Mutant IDH1 Promotes Glioma Formation In Vivo-Reference-Cited by-同舟云学术

Mutant IDH1 Promotes Glioma Formation In Vivo

Published:2018-05 Issue:5 Volume:23 Page:1553-1564
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Philip Beatrice,Yu Diana X.,Silvis Mark R.,Shin Clifford H.,Robinson James P.,Robinson Gemma L.,Welker Adam E.,Angel Stephanie N.,Tripp Sheryl R.,Sonnen Joshua A.,VanBrocklin Matthew W.,Gibbons Richard J.,Looper Ryan E.,Colman Howard,Holmen Sheri L.

Funder

National Cancer Institute

National Institute of Neurological Disorders and Stroke

NCI

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference43 articles.

1. ImageJS: Personalized, participated, pervasive, and reproducible image bioinformatics in the web browser;Almeida;J. Pathol. Inform.,2012

2. Mutant IDH1 regulates the tumor-associated immune system in gliomas;Amankulor;Genes Dev.,2017

3. Expression of Idh1R132Hin the murine subventricular zone stem cell niche recapitulates features of early gliomagenesis;Bardella;Cancer Cell,2016

4. Properties and regulation of glutamine transporter SN1 by protein kinases SGK and PKB;Boehmer;Biochem. Biophys. Res. Commun.,2003

5. Comprehensive, integrative genomic analysis of diffuse lower-grade gliomas;Brat;N. Engl. J. Med.,2015

Cited by 86 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Divergent effects of acute and chronic PPT1 inhibition in melanoma;Autophagy;2024-09-12

2. FAM109B plays a tumorigenic role in low-grade gliomas and is associated with tumor-associated macrophages (TAMs);Journal of Translational Medicine;2024-09-10

3. Development of a hydrogen peroxide fluorescent probe for the rapid discrimination of IDH1 mutant gliomas from the wild-type;Sensors and Actuators B: Chemical;2024-08

4. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma;Acta Neuropathologica;2024-07-16

5. IDH inhibition in gliomas: from preclinical models to clinical trials;Nature Reviews Neurology;2024-05-17